Clinical Studies on Endovenous Laser Ablation: A Comprehensive Review
Introduction
Varicose veins, a common manifestation of chronic venous insufficiency (CVI), affect a significant portion of the global population, leading to symptoms ranging from cosmetic concerns to considerable pain and discomfort, ultimately impacting patients' quality of life [1]. Historically, surgical stripping was the primary treatment, but advancements in medical technology have introduced less invasive alternatives. Among these, Endovenous Laser Ablation (EVLA) has emerged as a widely adopted and recommended method for treating varicose veins [2]. This review aims to synthesize current clinical evidence regarding the efficacy, safety, and patient outcomes associated with EVLA, providing a comprehensive overview for both patients seeking treatment options and healthcare professionals evaluating therapeutic strategies.
Understanding Endovenous Laser Ablation (EVLA)
EVLA is a minimally invasive procedure that utilizes laser energy to ablate, or close off, incompetent superficial veins, most commonly the Great Saphenous Vein (GSV). The procedure typically involves the insertion of a laser fiber into the affected vein under ultrasound guidance. Tumescent anesthesia, a dilute solution of local anesthetic, is then infiltrated around the vein, serving multiple purposes: it provides anesthesia, compresses the vein to ensure good contact with the laser fiber, and acts as a heat sink to protect surrounding tissues [3]. The laser energy is then delivered as the fiber is slowly withdrawn, causing irreversible thermal damage to the vein wall, leading to its occlusion and eventual fibrosis. This technique offers several advantages over traditional surgical methods, including reduced invasiveness, shorter recovery times, lower risk of complications, and decreased healthcare costs [2].
Efficacy of EVLA: Clinical Evidence
Clinical studies consistently demonstrate the high technical success and efficacy of EVLA in treating varicose veins. A retrospective review by Alwahbi et al. (2025) reported an impressive 98% technical success rate for outpatient EVLA performed under local tumescent anesthesia, with procedures typically lasting around 36 minutes [2]. This success rate aligns with previous research indicating EVLA occlusion rates often exceeding 95% [2].
Long-term outcomes are crucial for assessing the durability of varicose vein treatments. The Comparison of Laser, Surgery, and Foam Sclerotherapy (CLASS) trial, a large multicenter randomized controlled trial, provided valuable 5-year follow-up data. Brittenden et al. (2019) reported that disease-specific quality of life, as measured by the Aberdeen Varicose Vein Questionnaire (AVVQ), was significantly better after laser ablation or surgery compared to foam sclerotherapy at 5 years post-treatment [4]. Furthermore, the majority of probabilistic cost-effectiveness model iterations favored laser ablation, highlighting its economic viability alongside its clinical effectiveness [4].
Comparative studies have also evaluated EVLA against other contemporary treatments. While some medium-term follow-up studies suggested equivalent recurrence rates and quality of life at 2 and 3 years across laser ablation, foam sclerotherapy, and surgery, the 5-year data from the CLASS trial indicated superior disease-specific quality of life for EVLA and surgery over foam sclerotherapy [4]. Other research comparing EVLA with radiofrequency ablation (RFA) has shown similar efficacy in terms of early and long-term occlusion rates of the GSV and comparable incidence of thrombotic and phlebitis complications [5].
Safety Profile and Complications
The safety profile of EVLA is generally favorable, with a low incidence of significant complications. The study by Alwahbi et al. (2025) noted only minor complications such as bruising (13%) and phlebitis (5%), all of which resolved without further intervention [2]. Crucially, no significant complications like deep vein thrombosis (DVT) or pulmonary embolism (PE) were observed in their cohort [2]. Patients typically experienced a rapid recovery, resuming normal activities within approximately seven days, and reported high satisfaction levels [2].
Another prospective study involving 30 patients undergoing EVLA also reported no major complications (recurrence or recanalization) at the time of the study, though minor complications like bruising, postoperative pain, superficial thrombophlebitis, and skin burns were observed and responsive to medical treatment [3]. These findings underscore EVLA's safety when performed by experienced practitioners.
Patient and Healthcare Professional Perspectives
From a patient's perspective, EVLA offers significant advantages. Its minimally invasive nature translates to less pain, shorter hospital stays (often performed as an outpatient procedure under local anesthesia), and a quicker return to daily activities compared to traditional surgery [2, 3]. The avoidance of surgical incisions and the reduced risk of post-operative discomfort contribute to high patient satisfaction [2, 3].
For healthcare professionals and systems, EVLA presents an attractive option due to its high technical efficiency, cost-effectiveness, and the potential for outpatient delivery, which can alleviate bed scarcity and reduce overall healthcare expenditures [2, 4]. The robust clinical evidence supporting its efficacy and safety makes it a first-line treatment recommendation for incompetent truncal varicose veins [3].
Future Directions and Ongoing Research
Research in endovenous therapies continues to evolve, with ongoing studies exploring different laser wavelengths (e.g., 980 nm vs. 1470 nm), novel ablation techniques, and long-term comparative effectiveness against newer modalities like endovenous microwave ablation [5, 6]. These investigations aim to further refine EVLA protocols, optimize patient outcomes, and expand its applicability.
Disclaimer
**This blog post is intended for informational purposes only and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for diagnosis, treatment, and any medical concerns related to varicose veins or Endovenous Laser Ablation.**
Conclusion
Endovenous Laser Ablation stands as a well-established, highly effective, and safe minimally invasive treatment for varicose veins. Supported by a growing body of clinical evidence, including studies demonstrating high technical success rates, favorable long-term quality of life outcomes, and a low incidence of complications, EVLA offers significant benefits for patients and healthcare systems alike. Its role as a preferred first-line treatment underscores its value in modern venous disease management.
References
[1] Alwahbi, A. (2025). *Technical Efficacy and Safety of Outpatient Endovenous Laser Ablation of Varicose Veins Under Local Anesthesia*. Vasc Health Risk Manag, 21, 403–409. [https://pmc.ncbi.nlm.nih.gov/articles/PMC12094488/](https://pmc.ncbi.nlm.nih.gov/articles/PMC12094488/) [2] Elzefzaf, N., et al. (2023). *Evaluation of Endovenous Laser Ablation in the Management of Varicose Veins*. Cureus, 15(9), e45096. [https://pmc.ncbi.nlm.nih.gov/articles/PMC10569145/](https://pmc.ncbi.nlm.nih.gov/articles/PMC10569145/) [3] Brittenden, J., et al. (2019). *Five-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins*. N Engl J Med, 381, 912–922. [https://www.nejm.org/doi/full/10.1056/NEJMoa1805186](https://www.nejm.org/doi/full/10.1056/NEJMoa1805186) [4] Malskat, W. S. J., et al. (2019). *Commonly Used Endovenous Laser Ablation (EVLA) Parameters...*. EJVES, 58(1), 82-89. [https://www.ejves.com/article/S1078-5884(18)30813-X/fulltext](https://www.ejves.com/article/S1078-5884(18)30813-X/fulltext) [5] Li, Y., et al. (2022). *Efficacy and safety of endovenous microwave ablation versus endovenous laser ablation in patients with great saphenous vein varicosis: a multicentre, randomised controlled non-inferiority trial*. BMJ Open, 12(5), e059213. [https://bmjopen.bmj.com/content/12/5/e059213](https://bmjopen.bmj.com/content/12/5/e059213) [6] Kalaij, A. G. I., et al. (2025). *Efficacy and Safety of Endovenous Microwave Ablation Versus Endovenous Laser Ablation for Varicose Veins in Chronic Great Saphenous Vein Insufficiency: A Systematic Review and Meta-Analysis*. Annals of Vascular Surgery. [https://www.sciencedirect.com/science/article/abs/pii/S0890509625000251](https://www.sciencedirect.com/science/article/abs/pii/S0890509625000251)